Table 2.
Univariate and multivariate analyses of overall survival in MSKCC cohort
| Parameter | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| HR | 95% CI | P value | HR | 95% CI | P value | |
| Sex | ||||||
| Male vs. Female | 0.517 | 0.283-0.942 | 0.031 | 0.441 | 0.239-0.817 | 0.009 |
| Age | ||||||
| > 60 vs. ≤ 60 | 0.506 | 0.255-1.003 | 0.051 | |||
| RNF43 gene | ||||||
| MUT vs. WT | 0.122 | 0.032-0.552 | 0.006 | 0.128 | 0.025-0.747 | 0.022 |
| Tumor location | ||||||
| Rectum vs. others | 0.858 | 0.337-2.185 | 0.748 | |||
| Drug type | ||||||
| PD-L1/1 vs. others | 0.992 | 0.305-3.224 | 0.989 | |||
| TMB status | ||||||
| > median vs. ≤ median | 0.628 | 0.340-1.158 | 0.136 | |||
| MSI status | ||||||
| MSI-H vs. MSS | 0.264 | 0.103-0.678 | 0.006 | 0.716 | 0.244-2.104 | 0.544 |